Literature DB >> 30635443

Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression.

Hidemasa Goto1, Toyoaki Natsume2,3, Masato T Kanemaki2,3, Aika Kaito4, Shujie Wang5, Esteban C Gabazza6, Masaki Inagaki4, Akira Mizoguchi5.   

Abstract

Chk1 (encoded by CHEK1 in mammals) is an evolutionarily conserved protein kinase that transduces checkpoint signals from ATR to Cdc25A during the DNA damage response (DDR). In mammals, Chk1 also controls cellular proliferation even in the absence of exogenous DNA damage. However, little is known about how Chk1 regulates unperturbed cell cycle progression, and how this effect under physiological conditions differs from its regulatory role in DDR. Here, we have established near-diploid HCT116 cell lines containing endogenous Chk1 protein tagged with a minimum auxin-inducible degron (mAID) through CRISPR/Cas9-based gene editing. Establishment of these cells enabled us to induce specific and rapid depletion of the endogenous Chk1 protein, which resulted in aberrant accumulation of DNA damage factors that induced cell cycle arrest at S or G2 phase. Cdc25A was stabilized upon Chk1 depletion before the accumulation of DNA damage factors. Simultaneous depletion of Chk1 and Cdc25A partially suppressed the defects caused by Chk1 single depletion. These results indicate that, similar to its function in DDR, Chk1 controls normal cell cycle progression mainly by inducing Cdc25A degradation.
© 2019. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  AID; Auxin-inducible degron; Cdc25A; Cell cycle progression; Chk1

Mesh:

Substances:

Year:  2019        PMID: 30635443     DOI: 10.1242/jcs.223123

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

1.  A degron system targeting endogenous PD-1 inhibits the growth of tumor cells in mice.

Authors:  Chie Naruse; Kazushi Sugihara; Tatsuhiko Miyazaki; Xuchi Pan; Fumihiro Sugiyama; Masahide Asano
Journal:  NAR Cancer       Date:  2022-06-17

2.  Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways.

Authors:  Soichiro S Ito; Yosuke Nakagawa; Masaya Matsubayashi; Yoshihiko M Sakaguchi; Shinko Kobashigawa; Takeshi K Matsui; Hitoki Nanaura; Mari Nakanishi; Fumika Kitayoshi; Sotaro Kikuchi; Atsuhisa Kajihara; Shigehiro Tamaki; Kazuma Sugie; Genro Kashino; Akihisa Takahashi; Masatoshi Hasegawa; Eiichiro Mori; Tadaaki Kirita
Journal:  J Biol Chem       Date:  2020-07-16       Impact factor: 5.157

Review 3.  Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.

Authors:  Tao Wu; Hojong Yoon; Yuan Xiong; Sarah E Dixon-Clarke; Radosław P Nowak; Eric S Fischer
Journal:  Nat Struct Mol Biol       Date:  2020-06-15       Impact factor: 15.369

4.  The human origin recognition complex is essential for pre-RC assembly, mitosis, and maintenance of nuclear structure.

Authors:  Hsiang-Chen Chou; Kuhulika Bhalla; Osama El Demerdesh; Olaf Klingbeil; Kaarina Hanington; Sergey Aganezov; Peter Andrews; Habeeb Alsudani; Kenneth Chang; Christopher R Vakoc; Michael C Schatz; W Richard McCombie; Bruce Stillman
Journal:  Elife       Date:  2021-02-01       Impact factor: 8.140

5.  [Cell Cycle Checkpoint Kinase and Drug Resistance of Lung Cancer].

Authors:  Zhiyin Ke; Ailing Liang; Yongjun Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-04-20

6.  Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.

Authors:  Jennifer P Ditano; Nandini Sakurikar; Alan Eastman
Journal:  Cell Cycle       Date:  2021-06-22       Impact factor: 5.173

7.  Cdc7 kinase stimulates Aurora B kinase in M-phase.

Authors:  Sayuri Ito; Hidemasa Goto; Kinue Kuniyasu; Mayumi Shindo; Masayuki Yamada; Kozo Tanaka; Gaik-Theng Toh; Masaaki Sawa; Masaki Inagaki; Jiri Bartek; Hisao Masai
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

Review 8.  Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.

Authors:  Win Topatana; Sarun Juengpanich; Shijie Li; Jiasheng Cao; Jiahao Hu; Jiyoung Lee; Kenneth Suliyanto; Diana Ma; Bin Zhang; Mingyu Chen; Xiujun Cai
Journal:  J Hematol Oncol       Date:  2020-09-03       Impact factor: 17.388

Review 9.  DNA replication and mitotic entry: A brake model for cell cycle progression.

Authors:  Bennie Lemmens; Arne Lindqvist
Journal:  J Cell Biol       Date:  2019-11-11       Impact factor: 10.539

10.  Identifying the Key Genes in Mouse Liver Regeneration After Partial Hepatectomy by Bioinformatics Analysis and in vitro/vivo Experiments.

Authors:  Jian Zhao; Shi-Zhe Yu; Qiang Cai; Duo Ma; Long Jiang; Ling-Peng Yang; Zhi-Yong Yu
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.